Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
August 04, 2022 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
August 02, 2022 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
July 18, 2022 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Announces Update to Its GMP Manufacturing Strategy
June 21, 2022 08:30 ET
|
Generation Bio Co.
Company projects smaller GMP manufacturing footprint, enabled by further process development of rapid enzymatic synthesis of ceDNA at scale Company will seek to sublease its planned GMP facility, and...
Generation Bio to Present at the 2022 Jefferies Healthcare Conference
June 02, 2022 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
May 05, 2022 16:15 ET
|
Generation Bio Co.
Company continues to optimize cell-targeted lipid nanoparticle (ctLNP) delivery system for nonviral genetic medicine applications in liver, retina and vaccines Cash balance of...
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
April 05, 2022 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
March 02, 2022 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
February 24, 2022 16:20 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer
February 10, 2022 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...